Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the trial is adopted Fuzheng Huayu tablets against posthepatitic
cirrhosis, and to build a standard evaluation system for efficacy of traditional Chinese
medicine (TCM).
The second purpose is according to the international clinical guideline and the specialty of
TCM to build a standard clinical trial regulation for traditional Chinese medicine.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine